Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GSI EXIM America is the North American subsidiary of GSI Creos Corporation, a global Japanese trading company with a significant presence in the life sciences sector. The company's Life Science division acts as a strategic partner for biotech and pharmaceutical firms, providing specialized distribution services for raw materials, active pharmaceutical ingredients (APIs), and medical devices. They leverage their parent company's extensive global network to offer sourcing, logistics, and regulatory compliance support. Beyond traditional chemical supply, GSI EXIM America also distributes advanced materials like cup-stacked carbon nanotubes (CSNTs) for use in innovative medical technologies. Their business model focuses on bridging the gap between international manufacturers and the U.S. healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GSI EXIM America.